Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Association Clinique Thérapeutique Infantile du val de Marne
This study is based to data collection of cases (patients with MIS-C) compare to controls (patients with SARS-CoV-2 infection) occurring between 01 sep 2021 and 30 apr 2022. For this study cases and controls group will be matched for analyses.
The main of this study is to evaluate the difference of risk of occurrence of MIS-C between a first SARS-CoV-2 infection and a reinfection with SARS-CoV-2.
Age
0–18
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
group 1: cases
Patients with MIS-C (following SARS CoV-2 infection)
Hospitalised between the 01 sep 2021 and 30 apr 2022
Under 18 years of age
Not vaccinated for SARS-CoV-2
group 2: controls
Patients not hospitalised, treated by outpatient care
With documented SARS-CoV-2 infection between the 01 sep 2021 and 30 apr 2022
Matched with a case on age (+/- 6 months), gender and country
Not vaccinated for SARS-CoV-2
You may not be if
\- Refusal to participate by patient relative or legal representative
Clareo Health | COVID-19 and Multisystem Inflammatory Syndrome in Children (MIS-C) Risk / World Health Organization (WHO)
